Sanofi Completes Protein Sciences Buy

08:09 EDT 8 Sep 2017 | CHEManager

Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal enhances the presence of Sanofi’s global vaccines global business unit Sanofi Pasteur in the influenza vaccine market.

Original Article: Sanofi Completes Protein Sciences Buy


More From BioPortfolio on "Sanofi Completes Protein Sciences Buy"

Quick Search

Relevant Topics

Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...